HLVX vs SERA
Comparison between HilleVax Inc (HLVX, Company) and Sera Prognostics Inc Class A (SERA, Company).
Both HLVX and SERA are from the Healthcare sector.
HLVX vs SERA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
HLVX
$105M
SERA
$105M
Max Drawdown
HLVX
93.71%
Winner
SERA
91.10%
Sharpe Ratio
Winner
HLVX
0.44
SERA
-0.03
5Y Beta
HLVX
N/A
SERA
1.09
Industry
HLVX
Biotechnology
SERA
Medical Devices
P/E Ratio
HLVX
-1.45
Winner
SERA
-3.04
Debt to Equity
HLVX
0.00%
SERA
0.00%
Free Cash Flow Yield
HLVX
-57.13%
Winner
SERA
-26.38%
P/S Ratio
HLVX
N/A
SERA
1428.95
P/B Ratio
Winner
HLVX
0.71
SERA
1.33
HLVX vs SERA - Historical Returns
Returns include dividend reinvestment.
1M
HLVX
+1.46%
Winner
SERA
+17.93%
3M
Winner
HLVX
+12.97%
SERA
+2.36%
6M
Winner
HLVX
+18.08%
SERA
-33.02%
1Y
Winner
HLVX
+15.47%
SERA
-30.23%
5Y(CAGR)
HLVX
N/A
SERA
-26.33%
Max(CAGR)
HLVX
-47.96%
Winner
SERA
-28.75%
HLVX vs SERA - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | HLVX | SERA |
|---|---|---|
| 2026 | N/A | -27.67% |
| 2025 | +0.48% | -64.59% |
| 2024 | -86.39% | +36.35% |
| 2023 | +6.29% | +356.49% |
| 2022 | -12.36% | -83.57% |
| 2021 | N/A | -42.27% |
HLVX vs SERA Drawdown Comparison
The maximum drawdown for HLVX was -93.71%, occurring on Apr 1, 2025. This drawdown has not yet recovered.
The maximum drawdown for SERA was -91.10%, occurring on Dec 28, 2022. This drawdown has not yet recovered.
The current HLVX drawdown is -90.50%. The current SERA drawdown is -83.36%.
| Rank | HLVX | SERA |
|---|---|---|
| #1 | -93.71% Sep 13, 2022 - Apr 1, 2025 | -91.10% Aug 9, 2021 - Dec 28, 2022 |
| #2 | -56.89% May 3, 2022 - Sep 13, 2022 | -23.11% Jul 15, 2021 - Aug 2, 2021 |
| #3 | N/A | -8.00% Aug 2, 2021 - Aug 5, 2021 |
Correlation
Correlation between HLVX and SERA is -0.23 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.23
-101
Select Stocks to Compare
Popular: HLVX vs SPYSERA vs SPY
More Comparisons
Compare with similar stocks